XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Operations (Unaudited)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Revenues:        
Total revenue $ 1,164,617 $ 1,957,500 $ 2,524,819 $ 2,678,013
Costs and expenses:        
Costs of research and development revenue 254,753 395,894 529,690 841,805
Costs of grant revenue 769,250 1,405,562
Research and development 571,872 460,241 1,696,230 1,498,593
General and administrative 1,481,356 1,297,984 4,514,324 4,694,334
Foreign currency exchange loss 12,755 5,995 35,925 14,044
Total costs and expenses 3,089,986 2,160,114 8,181,731 7,048,776
Loss from operations (1,925,369) (202,614) (5,656,912) (4,370,763)
Other income (expense):        
Interest income 63,467 127,331 201,052 353,245
Total other income (expense), net (50,643) (846) (140,453) 112,484
Net loss $ (1,976,012) $ (203,460) $ (5,797,365) $ (4,258,279)
Basic net loss per common share | $ / shares $ (0.06) $ (0.01) $ (0.17) $ (0.15)
Diluted net loss per common share | $ / shares $ (0.06) $ (0.01) $ (0.17) $ (0.15)
Basic weighted-average common shares outstanding | shares 34,507,530 29,503,143 34,507,530 29,503,143
Diluted weighted-average common shares outstanding | shares 34,507,530 29,503,143 34,507,530 29,503,143
Nonrelated Party [Member]        
Other income (expense):        
Interest expense $ (85,934) $ (88,833) $ (264,633) $ (199,106)
Related Party [Member]        
Other income (expense):        
Interest expense (28,176) (39,344) (76,872) (102,632)
Research and Development [Member]        
Revenues:        
Total revenue 350,046 532,500 746,595 1,253,013
Grant [Member]        
Revenues:        
Total revenue 814,571 1,528,224
License [Member]        
Revenues:        
Total revenue $ 1,425,000 $ 250,000 $ 1,425,000